ArticleESMO real world data and digital oncology2026
Age and frailty in anticancer drug regulatory assessment: a comprehensive cohort study of European marketing authorisations 2012-2023.
O Tenhunen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.